1991
DOI: 10.1136/bmj.303.6802.543
|View full text |Cite|
|
Sign up to set email alerts
|

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
86
1
3

Year Published

1998
1998
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 235 publications
(94 citation statements)
references
References 36 publications
4
86
1
3
Order By: Relevance
“…These results are consistent with previous studies in international literature, in which platelet counts have been monitored in several large clinical trials that compared UFH with LMWH as antithrombotic prophylaxis after hip surgery or for the treatment of deep venous thrombosis [16]. The investigators found that HIT occurred in 2 out of 199 patients (1.0%) who received UFH after hip-replacement surgery, as compared with none of 198 patients who received LMWH; both patients with thrombocytopenia also had proximal deep venous thrombosis [17].…”
Section: Discussionsupporting
confidence: 83%
“…These results are consistent with previous studies in international literature, in which platelet counts have been monitored in several large clinical trials that compared UFH with LMWH as antithrombotic prophylaxis after hip surgery or for the treatment of deep venous thrombosis [16]. The investigators found that HIT occurred in 2 out of 199 patients (1.0%) who received UFH after hip-replacement surgery, as compared with none of 198 patients who received LMWH; both patients with thrombocytopenia also had proximal deep venous thrombosis [17].…”
Section: Discussionsupporting
confidence: 83%
“…Fifteen articles were eligible for analysis (Table 1) and were grouped into 3 categories, as follows: 2 RCTs measuring HIT as an outcome 3,11 ; 3 nonrandomized prospective studies with a comparison group (concurrent or sequential control group) and measuring HIT as an outcome 12-14 ; 10 RCTs not measuring HIT but appropriately monitoring thrombocytopenia as an outcome. [15][16][17][18][19][20][21][22][23][24] We performed 3 different analyses.…”
Section: Resultsmentioning
confidence: 99%
“…In our study the ratio of proximal to calf DVT in the placebo group was 1 : 1.6. By contrast, in European and North American studies the ratio was 1 : 4 in patients receiving LMWH prophylaxis [3,7].…”
Section: Discussionmentioning
confidence: 86%
“…From the 4th to the 10th days after operation the dosage was increased to 62 IU/kg per single subcutaneous injection. This regime is similar to that used by Leyvraz et al [7], and is the dose recommended by the manufacturer.…”
Section: Methodsmentioning
confidence: 86%
See 1 more Smart Citation